Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Manitowoc
MTW
$675M
| $401K | ﹤0.01% |
36,865
+4,990
| +16% | +$47.2K |
|
3477
Schneider National
SNDR
$6.25B
| $401K | ﹤0.01% |
16,230
+1,076
| +7% | +$23.7K |
|
|
PETQ
3478
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $401K | ﹤0.01% |
11,481
+4,895
| +74% | +$137K |
|
3479
Kornit Digital
KRNT
$791M
| $400K | ﹤0.01% |
+7,500
| New | +$286K |
|
3480
Nutrien
NTR
$30.7B
| $400K | ﹤0.01% |
12,483
-162,307
| -93% | -$5.65M |
|
3481
Quince Therapeutics
QNCX
$29.5M
| $400K | ﹤0.01% |
43
+24
| +126% | +$220K |
|
3482
RPC Inc
RES
$1.3B
| $400K | ﹤0.01% |
130,012
+3,456
| +3% | +$10.5K |
|
3483
IMAX
IMAX
$2.66B
| $399K | ﹤0.01% |
35,696
-94,011
| -72% | -$1.1M |
|
3484
Kirby Corp
KEX
$6.93B
| $399K | ﹤0.01% |
7,448
-69,754
| -90% | -$3.56M |
|
|
ACBI
3485
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $399K | ﹤0.01% |
32,876
+23,840
| +264% | +$274K |
|
|
HTZ
3486
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $399K | ﹤0.01% |
283,495
-148,278
| -34% | -$471K |
|
|
FAZ
3487
PUT
Direxion Daily Financial Bear 3x ETF
FAZ
$86.7M
| $398K | ﹤0.01% |
281
-1,941
| -87% | -$3.68M |
|
3488
LeMaitre Vascular
LMAT
$1.86B
| $398K | ﹤0.01% |
15,072
+1,410
| +10% | +$36.9K |
|
3489
Newmark Group
NMRK
$2.63B
| $398K | ﹤0.01% |
81,967
+31,942
| +64% | +$134K |
|
|
AMED
3490
PUT
DELISTED
Amedisys
AMED
| $397K | ﹤0.01% |
2,000
-7,400
| -79% | -$1.38M |
|
|
LNW
3491
PUT
DELISTED
Light & Wonder
LNW
| $397K | ﹤0.01% |
25,700
-25,200
| -50% | -$329K |
|
3492
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $396K | ﹤0.01% |
20,052
+5,228
| +35% | +$104K |
|
3493
Tidewater
TDW
$4.12B
| $394K | ﹤0.01% |
70,634
+9,031
| +15% | +$51.3K |
|
3494
Ternium
TX
$10.6B
| $394K | ﹤0.01% |
25,978
+793
| +3% | +$11.5K |
|
3495
Wave Life Sciences
WVE
$1.2B
| $394K | ﹤0.01% |
37,884
+5,091
| +16% | +$47.9K |
|
3496
Alaunos Therapeutics
TCRT
$4.86M
| $393K | ﹤0.01% |
799
+367
| +85% | +$164K |
|
|
MTSC
3497
DELISTED
MTS Systems Corp
MTSC
| $393K | ﹤0.01% |
22,392
+7,207
| +47% | +$133K |
|
3498
Consolidated Water Co
CWCO
$488M
| $392K | ﹤0.01% |
27,220
+19,682
| +261% | +$288K |
|
3499
Universal Display
OLED
$4.19B
| $392K | ﹤0.01% |
2,624
-29,784
| -92% | -$4.37M |
|
3500
PUT
Textron
TXT
$15.4B
| $392K | ﹤0.01% |
11,900
-7,400
| -38% | -$219K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.